Cancerclass: An R package for development and validation of diagnostic tests from high-dimensional molecular data

Journal of Statistical Software

Volumn 59, Issue 1, 2014, Pages

  Budczies, Jan ^a   Kosztyla, Daniel ^b   Von Törne, Christian ^c   Stenzinger, Albrecht ^d   Darb Esfahani, Silvia ^a   Dietel, Manfred ^a   Denkert, Carsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OLGAHOSPITAL   (Germany)

^c Siemens Healthcare Diagnostics   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Classification; Diagnostic test; Microarrays; Molecular data; R; Supervised learning

Indexed keywords

EID: 84920947713     PISSN: 15487660     EISSN: None     Source Type: Journal    
DOI: 10.18637/jss.v059.i01     Document Type: Article

References (44)

1. Ambroise C, McLachlan GJ (2002). “Selection Bias in Gene Extraction on the Basis of Microarray Gene Expression Data.” Proceedings of the National Academy of Sciences of the United States of America, 99(10), 6562-6566.
2. Andersen MH, Svane IM, Becker JC, Straten PT (2007). “The Universal Character of the Tumor-Associated Antigen Survivin.” Clinical Cancer Research, 13(20), 5991-5994.
3. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, Lecocke M, Metivier J, Booser D, Ibrahim N, Valero V, Royce M, Arun B, Whitman G, Ross J, Sneige N, Horto-bagyi GN, Pusztai L (2004). “Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer.” Journal of Clinical Oncology, 22(12), 2284-2293.
4. Braga-Neto U, Hashimoto R, Dougherty ER, Nguyen DV, Carroll RJ (2004). “Is CrossValidation Better than Resubstitution for Ranking Genes?” Bioinformatics, 20(2), 253-258.
5. Braga-Neto UM, Dougherty ER (2004). “Is Cross-Validation Valid for Small-Sample Microarray Classification?” Bioinformatics, 20(3), 374-380.
6. Budczies J, Kosztyla D (2011a). cancerclass: Development and Validation of Diagnostic Tests from High-Dimensional Molecular Data. R package version 1.8.0, URL http://www.Bioconductor.org/packages/release/bioc/html/cancerclass.html.
7. Budczies J, Kosztyla D (2011b). cancerdata: Development and Validation of Diagnostic Tests from High-Dimensional Molecular Data: Datasets. R package version 1.2.0, URL http://www.Bioconductor.org/packages/release/data/experiment/html/cancerdata.html
8. Cardoso F, Piccart-Gebhart M, Van’t Veer L, Rutgers E (2007). “The MINDACT Trial: The First Prospective Clinical Validation of a Genomic Tool.” Molecular Oncology, 1(3), 246-251.
9. Carlsson L, Larsson A, Lindman H (2009). “Elevated Levels of Thymidine Kinase 1 Peptide in Serum from Patients with Breast Cancer.” Upsala Journal of Medical Sciences, 114(2), 116-120.
10. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJW, Yang PC (2007). “A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer.” The New England Journal of Medicine, 356(1), 11-20.
11. Chen Y, Ying M, Chen Y, Hu M, Lin Y, Chen D, Li X, Zhang M, Yun X, Zhou J, He E, Skog S (2010). “Serum Thymidine Kinase 1 Correlates to Clinical Stages and Clinical Reactions and Monitors the Outcome of Therapy of 1,247 Cancer Patients in Routine Clinical Settings.” International Journal of Clinical Oncology, 15(4), 359-368.
12. Denkert C, Budczies J, Darb-Esfahani S, Györffy B, Sehouli J, Könsgen D, Zeillinger R, Weichert W, Noske A, Buckendahl AC, Möller BM, Dietel M, Lage H (2009). “A Prognostic Gene Expression Index in Ovarian Cancer - Validation Across Different Independent Data Sets.” Journal of Pathology, 218(2), 273-280.
13. Denkert C, Kronenwett R, Schlake W, Bohmann K, Penzel R, Weber KE, Hofler H, Lehmann U, Schirmacher P, Specht K, Rudas M, Kreipe HH, Schraml P, Schlake G, Bago-Horvath Z, Tiecke F, Varga Z, Moch H, Schmidt M, Prinzler J, Kerjaschki D, Sinn BV, Muller BM, Filipits M, Petry C, Dietel M (2012). “Decentral Gene Expression Analysis for ER+/HER2-Breast Cancer: Results of a Proficiency Testing Program for the EndoPredict Assay.” Virchows Archiv, 460(3), 251-259.
14. Dorai-Raj S (2014). binom: Binomial Confidence Intervals For Several Parameterizations. R package version 1.1-1, URL http://CRAN.R-pro ject.org/package=binom.
15. Dudoit S, Fridlyand J, Speed TP (2002). “Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data.” Journal of the American Statistical Association, 97(457), 77-87.
16. Efron B, Tibshirani R (1997). “Improvements of Cross-Validation: The .632+ Bootstrap Method.” Journal of the American Statistical Assocoation, 92(438), 548-560.
17. Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R (2007). “Metabolic Fingerprinting as a Diagnostic Tool.” Pharmacogenomics, 8(9), 1243-1266.
18. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, Andre S, Piccart M, Campone M, Brain E, Macgrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M (2009). “A Stroma-Related Gene Signature Predicts Resistance to Neoadjuvant Chemotherapy in Breast Cancer.” Nature Medicine, 15(1), 68-74.
19. Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer, F C, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Möller V, Janicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M (2011). “A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors.” Clinical Cancer Research, 17(18), 6012-6020.
20. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W (2009). “A Colorectal Cancer Expression Profile that Includes Transforming Growth Factor Beta Inhibitor BAMBI Predicts Metastatic Potential.” Gastroenterology, 137(1), 165-175.
21. Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K (2002). “Thymidine Kinase in Epithelial Ovarian Cancer: Relationship with the other Pyrimidine Pathway Enzymes.” International Journal of Cancer, 99(3), 328-335.
22. Gentleman RC, Carey VJ, Bates DM, B BB, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, L LT, Yang JY, Zhang J (2004). “Bioconductor: Open Software Development for Computational Biology and Bioinformatics.” Genome Biology, 5, R80.
23. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999). “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science, 286(5439), 531-537.
24. Liedtke C, Hatzis C, Symmans WF, Desmedt C, Haibe-Kains B, Valero V, Kuerer H, Hor-tobagyi GN, Piccart-Gebhart M, Sotiriou C, Pusztai L (2009). “Genomic Grade Index is Associated with Response to Chemotherapy in Patients with Breast Cancer.” Journal of Clinical Oncology, 27(19), 3185-3191.
25. Lottaz C, Kostka D, Markowetz F, Spang R (2008). “Computational Diagnostics with Gene Expression Profiles.” In JM Keith (ed.), Bioinformatics: Structure, Function and Applications, volume 453 of Methods in Molecular Biology, pp. 281-296. Humana Press.
26. Michiels S, Koscielny S, Hill C (2005). “Prediction of Cancer Outcome with Microarrays: A Multiple Random Validation Strategy.” Lancet, 365(9458), 488-492.
27. Popovici V, Chen W, Gallas BG, Hatzis C, Shi W, Samuelson FW, Nikolsky Y, Tsyganova M, Ishkin A, Nikolskaya T, Hess KR, Valero V, Booser D, Delorenzi M, Hortobagyi GN, Shi L, Symmans WF, Pusztai L (2010). “Effect of Training-Sample Size and Classification Difficulty on the Accuracy of Genomic Predictors.” Breast Cancer Research, 12(1), R5.
28. R Core Team (2014). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
29. Roepman P, Wessels LFA, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MGJ, Koole R, Hordijk GJ, Van der Vliet PC, Reinders MJT, Slootweg PJ, Holstege FCP (2005). “An Expression Profile for Diagnosis of Lymph Node Metastases from Primary Head and Neck Squamous Cell carcinomas.” Nature Genetics, 37(2), 182-186.
30. Service RF (2008). “Proteomics. Proteomics Ponders Prime Time.” Science, 321(5897), 1758-1761.
31. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, Barlogie B, Chen W, Du P, Fischer M, Furlanello C, Gallas BD, Ge X, Megherbi DB, Symmans WF, Wang MD, Zhang J, Bitter H, Brors B, Bushel PR, Bylesjo M, Chen M, Cheng J, Cheng J, Chou J, Davison TS, Delorenzi M, Deng Y, Devanarayan V, Dix DJ, Dopazo J, Dorff KC, Elloumi F, Fan J, Fan S, Fan X, Fang H, Gonzaludo N, Hess KR, Hong H, Huan J, Irizarry RA, Judson R, Juraeva D, Lababidi S, Lambert CG, Li L, Li Y, Li Z, Lin SM, Liu G, Lobenhofer EK, Luo J, Luo W, McCall MN, Nikolsky Y, Pennello GA, Perkins RG, Philip R, Popovici V, Price ND, Qian F, Scherer A, Shi T, Shi W, Sung J, Thierry-Mieg D, Thierry-Mieg J, Thodima V, Trygg J, Vishnuvajjala L, Wang SJ, Wu J, Wu Y, Xie Q, Yousef WA, Zhang L, Zhang X, Zhong S, Zhou Y, Zhu S, Arasappan D, Bao W, Lucas AB, Berthold F, Brennan RJ, Buness A, Catalano JG, Chang C, Chen R, Cheng Y, Cui J, Czika W, Demichelis F, Deng X, Dosymbekov D, Eils R, Feng Y, Fostel J, Fulmer-Smentek S, Fuscoe JC, Gatto L, Ge W, Goldstein DR, Guo L, Halbert DN, Han J, Harris SC, Hatzis C, Herman D, Huang J, Jensen RV, Jiang R, Johnson CD, Jurman G, Kahlert Y, Khuder SA, Kohl M, Li J, Li L, Li M, Li QZ, Li S, Li Z, Liu J, Liu Y, Liu Z, Meng L, Madera M, Martinez-Murillo F, Medina I, Meehan J, Miclaus K, Moffitt RA, Montaner D, Mukherjee P, Mulligan GJ, Neville P, Nikolskaya T, Ning B, Page GP, Parker J, Parry RM, Peng X, Peterson RL, Phan JH, Quanz B, Ren Y, Riccadonna S, Roter AH, Samuelson FW, Schumacher MM, Shambaugh JD, Shi Q, Shippy R, Si S, Smalter A, Sotiriou C, Soukup M, Staedtler F, Steiner G, Stokes TH, Sun Q, Tan PY, Tang R, Tezak Z, Thorn B, Tsyganova M, Turpaz Y, Vega SC, Visintainer R, von Frese J, Wang C, Wang E, Wang J, Wang W, Westermann F, Willey JC, Woods M, Wu S, Xiao N, Xu J, Xu L, Yang L, Zeng X, Zhang J, Zhang L, Zhang M, Zhao C, Puri RK, Scherf U, Tong W, Wolfinger RD (2010). “The MicroArray Quality Control (MAQC)-II Study of Common Practices for the Development and Validation of Microarray-Based Predictive Models.” Nature Biotechnology, 28(8), 827-838.
32. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, hui Fan X, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhang L, Zhong S, Zong Y, Slikker WJ (2006). “The MicroArray Quality Control (MAQC) Project Shows Inter- and Intraplatform Reproducibility of Gene Expression Measurements.” Nature Biotechnology, 24(9), 1151-1161.
33. Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y, Katagiri T (2007). “Elevated Expression of Protein Regulator of Cytokinesis 1, Involved in the Growth of Breast Cancer Cells.” Cancer Science, 98(2), 174-181.
34. Simon R, Radmacher MD, Dobbin K, McShane LM (2003). “Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification.” Journal of the National Cancer Institute, 95(1), 14-18.
35. Sparano JA (2006). “TAILORx: Trial Assigning Individualized Options for Treatment (Rx). Clinical Breast Cancer, 7(4), 347-350.
36. Stratton MR, Campbell PJ, Futreal PA (2009). “The Cancer Genome.” Nature, 458(7239), 719-724.
37. Tibshirani R, Hastie T (2007). “Outlier Sums for Differential Gene Expression Analysis.” Biostatistics, 8(1), 2-8.
38. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002). “Diagnosis of Multiple Cancer Types by Shrunken Centroids of Gene Expression.” Proceedings of the National Academy of Sciences of the United States of America, 99(10), 6567-6572.
39. Van de Vijver MJ, He YD, Van’t Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, Van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002). “A Gene-Expression Signature as a Predictor of Survival in Breast Cancer.” The New England Journal of Medicine, 347(25), 1999-2009.
40. Van’t Veer LJ, Dai H, Van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, Van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002). “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer.” Nature, 415(6871), 530-536.
41. Wessels LFA, Reinders MJT, Hart AAM, Veenman CJ, Dai H, He YD, Van’t Veer LJ (2005). “A Protocol for Building and Evaluating Predictors of Disease State Based on Microarray Data.” Bioinformatics, 21(19), 3755-3762.
42. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JAJ, Marks JR, Nevins JR (2001). “Predicting the Clinical Status of Human Breast Cancer by Using Gene Expression Profiles.” Proceedings of the National Academy of Sciences of the United States of America, 98(20), 11462-11467.
43. Wu B (2007). “Cancer Outlier Differential Gene Expression Detection.” Biostatistics, 8(3), 566-575.
44. Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati D (2008). “Overexpression of Separase Induces Aneuploidy and Mammary Tumorigenesis.” Proceedings of the National Academy of Sciences of the United States of America, 105(35), 13033-13038.